Skip to main content
. 2020 Oct 9;103(12):11676–11688. doi: 10.3168/jds.2019-18045

Figure 2.

Figure 2

Fish and flaxseed oil treatments depicted as a LSM percentage of control (CON) ± SEM for n-3 fatty acid (FA)-derived oxylipids (A) and n-6 FA-derived oxylipids (B) that differed from CON concentrations during the first week of age. Oxylipids were dihydroxy-eicosatetraenoic acid (DiHETE), dihydroxy-docosapentaenoic acid (DiHDPA), lipoxin (LX), and leukotriene (LT). Overall treatment P-values were as follows: 5,6-DiHETE: P < 0.01; 14,15-DiHETE: P < 0.001; 17,18-DiHETE: P = 0.01; 19,20-DiHDPA: P = 0.01; 5,6-LXA4: P = 0.06; LTB4: P = 0.02. Treatments (n = 6): CON = no supplement added to colostrum; FF30 = 30 mL of a 1:1 ratio fish and flaxseed oil blend added to colostrum; FF60 = 60 mL of a 1:1 ratio fish and flaxseed oil blend added to colostrum; FF120 = 120 mL of a 1:1 ratio fish and flaxseed oil blend added to colostrum.